Kexing Biopharm's GB18 Project Gains IND Approval from NMPA and FDA Kexing Biopharm celebrates a major milestone as their GB18 project receives Investigational New Drug approval from both NMPA and FDA.

Kexing Biopharm's GB18 Project Gains IND Approval from NMPA and FDA #China #Shenzhen #Kexing_Biopharm #GB18 #IND_approval